APA (7th ed.) Citation

Beldhuis, I. E., Heerspink, H. J., & Voors, A. A. (2025). Can the novel aldosterone inhibiting drug balcinrenone reduce hyperkalaemia and worsening renal function compared to steroidal mineralocorticoid receptor antagonists in heart failure? European Journal of Heart Failure, 27(2), 232. https://doi.org/10.1002/ejhf.3387

Chicago Style (17th ed.) Citation

Beldhuis, Iris E., Hiddo J.L Heerspink, and Adriaan A. Voors. "Can the Novel Aldosterone Inhibiting Drug Balcinrenone Reduce Hyperkalaemia and Worsening Renal Function Compared to Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure?" European Journal of Heart Failure 27, no. 2 (2025): 232. https://doi.org/10.1002/ejhf.3387.

MLA (9th ed.) Citation

Beldhuis, Iris E., et al. "Can the Novel Aldosterone Inhibiting Drug Balcinrenone Reduce Hyperkalaemia and Worsening Renal Function Compared to Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure?" European Journal of Heart Failure, vol. 27, no. 2, 2025, p. 232, https://doi.org/10.1002/ejhf.3387.